Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,357
Closed -$4.22M 248
2024
Q1
$4.08M Buy
+14,357
New +$4.2M 0.13% 46
2023
Q1
Sell
-2,103
Closed -$516K 416
2022
Q4
$552K Sell
2,103
-20
-0.9% -$5.36K 0.05% 255
2022
Q3
$479K Buy
+2,123
New +$515K 0.26% 73
2022
Q1
Sell
-1,713
Closed -$385K 351
2021
Q4
$385K Buy
+1,713
New +$362K 0.04% 123
2021
Q3
Sell
-992
Closed -$242K 402
2021
Q2
$242K Buy
+992
New +$244K 0.11% 174
2021
Q1
Sell
-1,163
Closed -$267K 468
2020
Q4
$267K Sell
1,163
-3,739
-76% -$862K 0.02% 154
2020
Q3
$1.25M Buy
+4,902
New +$1.21M 0.1% 20
2018
Q3
Sell
-1,189
Closed -$219K 389
2018
Q2
$219K Buy
+1,189
New +$210K 0.08% 125

Other funds holding AMGN

XR Securities's AMGN Position: Q2 2024 in Review

XR Securities sold out of Amgen (AMGN) in Q2 2024, closing a stake of 14,357 shares — an estimated $4.22M sold.

XR Securities first reported a position in AMGN in Q2 2018 and held it in 8 quarters. The position peaked at $4.08M in Q1 2024. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • XR Securities reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • XR Securities sold 14,357 Amgen shares in Q2 2024, an estimated $4.22M.
  • XR Securities first reported a position in Amgen in Q2 2018 and held it in 8 quarters.
  • XR Securities's Amgen position peaked at $4.08M in Q1 2024.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on XR Securities's 13F filing for Q2 2024, filed 5 Aug 2024.